Our findings and those of The Cancer Genome Atlas Research Network[2] now challenge the contribution of PALB2 methylation to the dysfunction of the BRCA/FA pathway in this histological subtype of ovarian cancer. This evidence concerns the gene PALB2 and ovarian carcinoma.